Tiansheng Pharmaceutical Group Co., Ltd. (SHE:002872)
China
· Delayed Price · Currency is CNY 5.41
-0.01 (-0.18%)
At close: Mar 10, 2026
SHE:002872 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 1,720 | 1,444 | 1,631 | 1,679 | 1,660 | 1,507 | Upgrade
|
| Market Cap Growth | 39.79% | -11.50% | -2.84% | 1.15% | 10.13% | -11.73% | Upgrade
|
| Enterprise Value | 1,779 | 1,600 | 1,714 | 1,849 | 1,903 | 1,907 | Upgrade
|
| Last Close Price | 5.41 | 4.54 | 5.13 | 5.28 | 5.22 | 4.74 | Upgrade
|
| PS Ratio | 3.33 | 2.53 | 2.82 | 2.77 | 2.25 | 1.25 | Upgrade
|
| PB Ratio | 0.87 | 0.72 | 0.78 | 0.77 | 0.73 | 0.63 | Upgrade
|
| P/TBV Ratio | 1.02 | 0.84 | 0.92 | 0.90 | 0.85 | 0.77 | Upgrade
|
| P/FCF Ratio | 53.87 | - | - | 106.52 | - | 15.53 | Upgrade
|
| P/OCF Ratio | 35.32 | 28.79 | - | 18.83 | 87.50 | 7.94 | Upgrade
|
| EV/Sales Ratio | 3.45 | 2.81 | 2.96 | 3.05 | 2.58 | 1.59 | Upgrade
|
| EV/EBITDA Ratio | 32.11 | 35.48 | 94.15 | 155.97 | 127.58 | - | Upgrade
|
| EV/FCF Ratio | 55.71 | - | - | 117.29 | - | 19.64 | Upgrade
|
| Debt / Equity Ratio | 0.17 | 0.18 | 0.16 | 0.15 | 0.18 | 0.25 | Upgrade
|
| Debt / EBITDA Ratio | 5.94 | 7.91 | 15.28 | 23.39 | 23.57 | - | Upgrade
|
| Debt / FCF Ratio | 10.31 | - | - | 20.88 | - | 6.04 | Upgrade
|
| Net Debt / Equity Ratio | 0.03 | 0.05 | 0.06 | 0.02 | 0.00 | 0.11 | Upgrade
|
| Net Debt / EBITDA Ratio | 0.94 | 2.15 | 7.30 | 4.30 | -0.46 | -45.90 | Upgrade
|
| Net Debt / FCF Ratio | 1.59 | -773.16 | -1.31 | 3.23 | 0.07 | 2.62 | Upgrade
|
| Asset Turnover | 0.19 | 0.21 | 0.20 | 0.20 | 0.22 | 0.30 | Upgrade
|
| Inventory Turnover | 2.33 | 2.54 | 2.41 | 2.19 | 2.14 | 2.99 | Upgrade
|
| Quick Ratio | 1.63 | 1.64 | 1.20 | 1.19 | 1.57 | 1.07 | Upgrade
|
| Current Ratio | 2.01 | 1.96 | 1.52 | 1.47 | 1.95 | 1.44 | Upgrade
|
| Return on Equity (ROE) | -4.81% | -4.29% | -4.38% | -4.10% | -3.10% | -18.51% | Upgrade
|
| Return on Assets (ROA) | -1.22% | -1.36% | -1.86% | -1.92% | -1.34% | -1.90% | Upgrade
|
| Return on Invested Capital (ROIC) | -2.59% | -2.79% | -3.85% | -4.15% | -2.95% | -4.12% | Upgrade
|
| Return on Capital Employed (ROCE) | -2.30% | -2.50% | -3.60% | -3.90% | -2.70% | -4.50% | Upgrade
|
| Earnings Yield | -5.60% | -6.05% | -5.71% | -5.39% | -4.08% | -32.56% | Upgrade
|
| FCF Yield | 1.86% | -0.01% | -6.21% | 0.94% | -5.75% | 6.44% | Upgrade
|
| Buyback Yield / Dilution | 0.04% | 0.01% | 0.00% | 0.01% | -0.01% | 0.50% | Upgrade
|
| Total Shareholder Return | 0.04% | 0.01% | 0.00% | 0.01% | -0.01% | 0.50% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.